Jefferies Provides Color On Integra LifeSciences Holdings
Jefferies published a note on Integra LifeSciences Holdings (NASDAQ: IART) today after the company's long-time CEO Stuart Essig stepped down. COO Peter Arduini will take his place. Jefferies has a Buy rating and $43 price target for Integra LifeSciences.
In the report, Jefferies stated, "Stuart Essig has been the chief architect of the acquisition-driven strategy that has served Integra well over the past 14 years. His departure likely represents a new chapter for the company, one more reliant on value creation through 'operating well' rather than through acquisition."
Shares of Integra LifeSciences Holdings closed at $31.19 today, down 0.22% from Tuesday's close.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.